MigraineMind research summary
Impacts of cervical exercise and Mulligan manual therapy on headache frequency, intensity, and disability for people with episodic migraine - a randomized clinical trial.
J Man Manip Ther | 2026
Clinical trialSummary
This study aimed to compare Mulligan manual therapy (MMT) with sham MMT. Researchers involved 99 adults with episodic migraine, averaging 41.5 years old. Participants received either neck exercises alone, exercises plus MMT, or exercises plus sham MMT. The primary outcome was migraine frequency. Secondary outcomes included headache intensity, duration, medication use, and disability. Evaluations occurred at baseline, and at 4, 13, and 26 weeks. Results showed no significant difference in headache frequency among the groups. At the 4-week mark, exercise plus MMT significantly reduced disability compared to exercises alone and exercise plus sham MMT. However, this improvement did not persist at later follow-ups. Improvements in upper cervical range of motion were observed at 13 and 26 weeks. The lack of significant headache frequency reduction may relate to not subgrouping migraine patients based on articular impairments. Clinical relevance: This research indicates that while disability may improve, headache frequency does not significantly change with MMT.
Key Learning Points
- Mulligan manual therapy combined with neck exercises may reduce disability in migraine patients initially, but this benefit does not last over time.
- There was no significant change in headache frequency among patients receiving different treatments.
- Improvements in neck movement were noted after 13 and 26 weeks, indicating some physical benefits from the therapy.
- The study suggests that not categorizing migraine patients by specific neck issues may have impacted the results.
- Clinicians should consider that while MMT may help with disability, it does not significantly affect the overall frequency of migraines.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.
